David Sutton

4.5k total citations
76 papers, 2.6k citations indexed

About

David Sutton is a scholar working on Epidemiology, Small Animals and Oncology. According to data from OpenAlex, David Sutton has authored 76 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 16 papers in Small Animals and 16 papers in Oncology. Recurrent topics in David Sutton's work include Herpesvirus Infections and Treatments (15 papers), Veterinary Equine Medical Research (11 papers) and Cytomegalovirus and herpesvirus research (10 papers). David Sutton is often cited by papers focused on Herpesvirus Infections and Treatments (15 papers), Veterinary Equine Medical Research (11 papers) and Cytomegalovirus and herpesvirus research (10 papers). David Sutton collaborates with scholars based in United Kingdom, United States and Australia. David Sutton's co-authors include M R Boyd, T. H. Bacon, Robert T. Sarisky, Teresa H. Bacon, Jeffry J. Leary, Myron J. Levin, Martin Cole, R. Anthony Vere Hodge, Richard L. Jarvest and Aidan G. Gilmartin and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

David Sutton

70 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sutton United Kingdom 24 997 880 594 280 232 76 2.6k
Angelina S. Palma Portugal 24 519 0.5× 1.1k 1.3× 277 0.5× 421 1.5× 218 0.9× 55 2.4k
Heng Fong Seow Malaysia 34 475 0.5× 1.2k 1.3× 482 0.8× 391 1.4× 230 1.0× 127 3.2k
Núria Gironès Spain 32 1.0k 1.0× 748 0.8× 152 0.3× 117 0.4× 164 0.7× 70 2.3k
Júlio Scharfstein Brazil 39 2.4k 2.4× 1.2k 1.4× 457 0.8× 237 0.8× 119 0.5× 109 4.3k
Jie Lu China 29 873 0.9× 1.2k 1.4× 499 0.8× 901 3.2× 74 0.3× 105 2.8k
Andrew I. Webb Australia 38 558 0.6× 2.6k 3.0× 559 0.9× 233 0.8× 288 1.2× 112 4.3k
Vladimir V. Kravchenko United States 27 497 0.5× 2.0k 2.3× 422 0.7× 288 1.0× 164 0.7× 52 4.7k
Devki Nandan Canada 23 647 0.6× 808 0.9× 250 0.4× 172 0.6× 129 0.6× 45 2.1k
Jeffry J. Leary United States 18 1.1k 1.1× 946 1.1× 252 0.4× 466 1.7× 237 1.0× 33 2.8k
Andrew Lees United States 34 899 0.9× 924 1.1× 188 0.3× 479 1.7× 102 0.4× 90 4.1k

Countries citing papers authored by David Sutton

Since Specialization
Citations

This map shows the geographic impact of David Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sutton more than expected).

Fields of papers citing papers by David Sutton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sutton. The network helps show where David Sutton may publish in the future.

Co-authorship network of co-authors of David Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of David Sutton. A scholar is included among the top collaborators of David Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sutton. David Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capewell, Paul, et al.. (2025). Equine trypanosomiasis, a systematic review and meta‐analyses: Prevalence, morbidity and mortality. Equine Veterinary Journal. 58(2). 291–319.
3.
Sutton, David, et al.. (2023). Treatment of equine sarcoids: A systematic review. Equine Veterinary Journal. 56(1). 12–25. 7 indexed citations
4.
McGuinness, David, et al.. (2022). A study comparing the healthy and diseased equine glandular gastric microbiota sampled with sheathed transendoscopic cytology brushes. Journal of Equine Veterinary Science. 116. 104002–104002. 8 indexed citations
5.
Marchesi, Francesco, et al.. (2021). Topical 5‐fluorouracil as an adjunct treatment in equine corneolimbal squamous cell carcinoma. Equine Veterinary Education. 34(9). 4 indexed citations
6.
McDonald, Michael, et al.. (2019). Analysis of Theileria equi diversity in The Gambia using a novel genotyping method. Transboundary and Emerging Diseases. 67(3). 1213–1221. 19 indexed citations
8.
Shiels, Brian, et al.. (2017). Molecular confirmation of Sarcocystis fayeri in a donkey. Veterinary Parasitology. 240. 30–33. 3 indexed citations
9.
Sutton, David, et al.. (2015). Arrhythmogenic right ventricular cardiomyopathy secondary to adipose infiltration as a cause of episodic collapse in a horse. Irish Veterinary Journal. 68(1). 19–19. 5 indexed citations
10.
Zhang, Lianhai, Yiqiang Liu, Xiaohong Wang, et al.. (2015). The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice. Scientific Reports. 5(1). 9447–9447. 35 indexed citations
12.
Gilmartin, Aidan G., Maureen R. Bleam, Arthur Groy, et al.. (2011). GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition. Clinical Cancer Research. 17(5). 989–1000. 459 indexed citations
13.
Sutton, David, Tom Preston, & S. Love. (2011). In vitro validation of the lactose 13 C‐ureide breath test for equine orocaecal transit time measurement. Equine Veterinary Journal. 43(s39). 42–48. 3 indexed citations
14.
Gilmartin, Aidan G., Maureen R. Bleam, Mark C. Richter, et al.. (2009). Distinct Concentration-Dependent Effects of the Polo-like Kinase 1–Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis. Cancer Research. 69(17). 6969–6977. 100 indexed citations
15.
Chua, Penelope, Radhika Desai, Stephen E. Schauer, et al.. (2007). Differential response of tumor cell lines to inhibition of the mitotic checkpoint regulator and mitotic kinesin, CENP-E. Molecular Cancer Therapeutics. 6. 3 indexed citations
16.
Sutton, David, Melody Diamond, Leo F. Faucette, et al.. (2007). Efficacy of GSK461364, a selective Plk1 inhibitor, in human tumor xenograft models. 67. 5388–5388. 4 indexed citations
17.
Wyse, Cathy, et al.. (2003). A Review of Methods for Assessment of the Rate of Gastric Emptying in the Dog and Cat: 1898–2002. Journal of Veterinary Internal Medicine. 17(5). 609–621. 52 indexed citations
18.
Sutton, David, Anne Bahr, Tom Preston, et al.. (2003). Validation of the 13C‐octanoic acid breath test for measurement of equine gastric emptying rate of solids using radioscintigraphy. Equine Veterinary Journal. 35(1). 27–33. 37 indexed citations
19.
Serafinowska, Halina T., et al.. (1995). Synthesis and in Vivo Evaluation of Prodrugs of 9-[2-(Phosphonomethoxy)ethoxy]adenine. Journal of Medicinal Chemistry. 38(8). 1372–1379. 45 indexed citations
20.
Harnden, Michael R., Paul G. Wyatt, Malcolm R. Boyd, & David Sutton. (1990). Synthesis and antiviral activity of 9-alkoxypurines. 1. 9-(3-Hydroxypropoxy)- and 9-[3-hydroxy-2-(hydroxymethyl)propoxy]purines. Journal of Medicinal Chemistry. 33(1). 187–196. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026